Genetically modified immune cells can offer precious additional time to patients with advanced multiple myeloma. However, these therapies lose their impact as the molecules on cancer cells that immune ...
Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
Newspoint on MSN
EPFO pension update: Will minimum pension rise to ₹10,000? Here's what the government said
For millions of retirees in India, pension income remains the backbone of financial security after leaving the workforce. Private-sector employees regularly contribute a portion of their salaries to ...
Compare Cyborg Avant with Indian Super Chief Dark Horse by price, specifications, features, mileage, engine performance, colours, images, etc at ZigWheels.
Compare Cyborg Avant vs Harley-Davidson Street Bob - Compare Cyborg Avant with Harley-Davidson Street Bob by price, specifications, features, mileage, engine performance, colours, images, etc at ...
The worldwide shift to renewable energy creates strong demand for Energy Storage Systems (ESS) in grid support, industrial uses, and home areas. Battery technologies advance steadily. The protective ...
Bristol Myers Squibb (NYSE: BMY; BMS) delivered some good news to investors in reporting fourth-quarter and full-year 2025 results on Thursday. The pharma giant beat analyst consensus forecasts by ...
Bristol Myers Squibb is partnering up with Evinova’s AI clinical development platform across the Big Pharma company’s global portfolio in an effort to improve efficiency and cut costs. The agreement ...
Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights ...
Electra announces a major milestone with the successful validation of its EVE‑Ai™ Adaptive Controls platform, enabling ...
In case you've faced some hurdles solving the clue, Basics, we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy leisure time, and test your ...
Bristol-Myers Squibb (BMS) reported stronger-than-expected earnings for the fourth quarter of 2025, with earnings per share (EPS) reaching $1.26, surpassing the anticipated $1.12. Revenue also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results